Feasibility of the Heparin Industry during the Covid 19 Crisis - A Snapshot of the Heparin Market

Rapid Rise in medical emergencies is leading to high demand for Heparin after the Covid 19 impact.

The Global Heparin Market was valued at USD 6.5 billion in 2020 and is expected to reach USD 9.7 billion by 2027, growing at a CAGR of 5.9% during the forecast period, 2021 - 2027.

Heparin doses are often used to treat a wide range of health problems such as deep vein thrombosis, acute coronary syndrome, atrial fibrillation, pulmonary embolism, and even cardiopulmonary bypass and hemofiltration during cardiac surgery, this extravagant usage is propelling the market growth. In addition, the supply of synthetic and semi-synthetic heparin mimetics that help treat cancer, coagulation, and inflammatory diseases is expected to provide a favorable opportunity for heparin adoption.

The Global Heparin Market Segmentation:

The global heparin market is segmented into product, application, distribution channel, route of administration, and region.

  • By Product Type
    • Low Molecular Weight Heparin (LMWH)
    • Ultra-low Molecular Weight Heparin (ULMWH)
  • By Application
    • Venous Thromboembolism
    • Coronary Artery Disease
    • Atrial Fibrillation
    • Others
  • By Distribution Channel
    • Hospital Pharmacies
    • Drug Stores & Retail Pharmacies
    • Online Pharmacies
  • By Route of Administration
    • Intravenous
    • Subcutaneous
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Company Profiles and Competitive Intelligence

The key players operating in the market are:

  • Baxter International Inc.
  • B. Braun Holding GmbH & Co. KG
  • Dr. Reddy’s Laboratories Ltd.
  • Fresenius SE & Co KGaA
  • Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
  • Leo Pharma A/S
  • Pfizer Inc.
  • Sanofi S.A
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • GlaxoSmithKline plc
  • Aspen Holdings
  • Emcure Pharmaceutical Pvt. Ltd.
  • Cipla Ltd.
  • Bharat Serum
  • Abbott Laboratories
  • Lupin Ltd.
  • Intas Pharmaceuticals Ltd.
  • Samarth Life Sciences Pvt. Ltd.
  • Claris Lifesciences Limited
  • Gland Pharma Limited
  • Mylan Pharmaceutical
  • Torrent Pharmaceuticals
  • Micro Labs Ltd. 
  • Troikaa Pharmaceuticals Ltd.
  • Biological E Limited
  • VHB Life Sciences Limited
  • Celon Laboratories Pvt. Ltd.
  • United Biotech (P) Limited

The report provides with an in-depth analysis of market trends, financial analysis, segmentation analysis, company profiles, recent news and much more. Heparin market is segmented into product, application, and distribution channel, route of administration, end use, and region. Based on product, the Low Molecular Weight Heparin (LMWH) segment is anticipated to hold the largest market in the forecast period. With longer predictable surgery and subcutaneous injections than UFH, easy self-management at home, reducing or eliminating hospitalizations and not requiring daily blood monitoring promotes the growth of low molecular weight heparin market segment. On the basis of applications, the coronary artery disease segment is accounted to dominate the market, owing to the increase in prevalence of heart- related disorders n past few years.

Geographically, the North American region is dominating the market with highest revenue. The supremacy is attributed to high healthcare expenditure, high healthcare related awareness and incorporation of enhanced and sophisticated healthcare infrastructure in the region. Moreover, the growing incidences of cardiovascular disorders and sports injuries are propelling the regional market growth. However, Asia pacific region is witnessing the highest CAGR in the upcoming years owing to the continuous developments in healthcare infrastructure, economic development, and untapped opportunities in these developing nations.  

Report also covers analysis of some of the key players including Fresenius SE & Co KGaA, B. Braun Holding GmbH & Co. KG, Baxter International Inc., Dr. Reddy’s Laboratories Ltd., and Aspen Holdings among others. These players have significantly adopted varied developmental strategies covered on our reports. The report also covers numerous market trends and upcoming opportunities in the near future.  

Global Heparin Market Report Highlights.

  • Based on distribution channel, the hospital pharmacies segment accounted for the highest share in 2020 which is accounted to the easy access and patients’ trust.
  • By route of administration, the subcutaneous segment registered for the largest share in the market in 2020. The growth is attributed to low cost associated with hospitalization compared to others.
  • Despite of the economic slowdown in the past few years due to the COVID-19 crisis, the heparin market is witnessing the upsurge owing to the increased cases of respiratory diseases in the COVID-19 outbreak.

Recent News

  • B. Braun Holding GmbH & Co. KG in June 2021 has announced a acquisition over Nutrichem, in order to strengthen the market base for B. Braun Holding Gmbh & Co. KG in the enteral nutrition and clinical nutrition fields.
  • In September 2019, the Baxter International Inc. announced its successful acquisition over Cheetah Medical, a company which provides non-invasive hemodynamic monitoring technologies. The transaction was worth for USD 40 million based on clinical and commercial milestones.

Quick Inquiry

Follow Us